Annual CFI
$54.83 M
-$40.26 M-42.34%
December 1, 2024
Summary
- As of March 10, 2025, ATHA annual cash flow from investing activities is $54.83 million, with the most recent change of -$40.26 million (-42.34%) on December 1, 2024.
- During the last 3 years, ATHA annual CFI has risen by +$58.91 million (+1444.20%).
- ATHA annual CFI is now -42.34% below its all-time high of $95.09 million, reached on December 31, 2023.
Performance
ATHA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$2.81 M
-$20.85 M-115.59%
December 1, 2024
Summary
- As of March 10, 2025, ATHA quarterly cash flow from investing activities is -$2.81 million, with the most recent change of -$20.85 million (-115.59%) on December 1, 2024.
- Over the past year, ATHA quarterly CFI has stayed the same.
- ATHA quarterly CFI is now -107.92% below its all-time high of $35.52 million, reached on March 31, 2023.
Performance
ATHA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$54.83 M
-$9.20 M-14.37%
December 1, 2024
Summary
- As of March 10, 2025, ATHA TTM cash flow from investing activities is $54.83 million, with the most recent change of -$9.20 million (-14.37%) on December 1, 2024.
- Over the past year, ATHA TTM CFI has stayed the same.
- ATHA TTM CFI is now -51.63% below its all-time high of $113.34 million, reached on September 30, 2023.
Performance
ATHA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ATHA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.3% | 0.0% | 0.0% |
| 3 y3 years | +1444.2% | 0.0% | 0.0% |
| 5 y5 years | +3540.8% | 0.0% | 0.0% |
ATHA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | +1444.2% | -107.9% | +37.0% | -51.6% | +1444.2% |
| 5 y | 5-year | -42.3% | +126.1% | -107.9% | +97.6% | -51.6% | +123.5% |
| alltime | all time | -42.3% | +126.1% | -107.9% | +97.6% | -51.6% | +123.5% |
Athira Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $54.83 M(-42.3%) | -$2.81 M(-115.6%) | $54.83 M(-14.4%) |
| Sep 2024 | - | $18.04 M(-32.1%) | $64.03 M(-4.0%) |
| Jun 2024 | - | $26.56 M(+103.7%) | $66.68 M(-8.2%) |
| Mar 2024 | - | $13.04 M(+104.1%) | $72.61 M(-23.6%) |
| Dec 2023 | $95.09 M(+64.9%) | $6.39 M(-69.1%) | $95.09 M(-16.1%) |
| Sep 2023 | - | $20.69 M(-36.3%) | $113.34 M(+6.6%) |
| Jun 2023 | - | $32.49 M(-8.5%) | $106.29 M(+53.3%) |
| Mar 2023 | - | $35.52 M(+44.1%) | $69.34 M(+20.2%) |
| Dec 2022 | $57.66 M | $24.65 M(+80.8%) | $57.66 M(+6.0%) |
| Sep 2022 | - | $13.63 M(-405.6%) | $54.39 M(+104.8%) |
| Jun 2022 | - | -$4.46 M(-118.7%) | $26.56 M(-37.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $23.85 M(+11.6%) | $42.48 M(-1141.3%) |
| Dec 2021 | -$4.08 M(-98.1%) | $21.37 M(-250.5%) | -$4.08 M(-97.1%) |
| Sep 2021 | - | -$14.20 M(-224.0%) | -$141.21 M(-36.2%) |
| Jun 2021 | - | $11.46 M(-150.4%) | -$221.32 M(-4.9%) |
| Mar 2021 | - | -$22.71 M(-80.4%) | -$232.78 M(+10.8%) |
| Dec 2020 | -$210.07 M(<-9900.0%) | -$115.76 M(+22.7%) | -$210.07 M(+122.7%) |
| Sep 2020 | - | -$94.31 M(<-9900.0%) | -$94.31 M(<-9900.0%) |
| Jun 2020 | - | $2000.00(+100.0%) | $3000.00(+200.0%) |
| Mar 2020 | - | $1000.00 | $1000.00 |
| Dec 2019 | $1.51 M(-25.0%) | - | - |
| Dec 2018 | $2.01 M | - | - |
FAQ
- What is Athira Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Athira Pharma?
- What is Athira Pharma annual CFI year-on-year change?
- What is Athira Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Athira Pharma?
- What is Athira Pharma quarterly CFI year-on-year change?
- What is Athira Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Athira Pharma?
- What is Athira Pharma TTM CFI year-on-year change?
What is Athira Pharma annual cash flow from investing activities?
The current annual CFI of ATHA is $54.83 M
What is the all time high annual CFI for Athira Pharma?
Athira Pharma all-time high annual cash flow from investing activities is $95.09 M
What is Athira Pharma annual CFI year-on-year change?
Over the past year, ATHA annual cash flow from investing activities has changed by -$40.26 M (-42.34%)
What is Athira Pharma quarterly cash flow from investing activities?
The current quarterly CFI of ATHA is -$2.81 M
What is the all time high quarterly CFI for Athira Pharma?
Athira Pharma all-time high quarterly cash flow from investing activities is $35.52 M
What is Athira Pharma quarterly CFI year-on-year change?
Over the past year, ATHA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Athira Pharma TTM cash flow from investing activities?
The current TTM CFI of ATHA is $54.83 M
What is the all time high TTM CFI for Athira Pharma?
Athira Pharma all-time high TTM cash flow from investing activities is $113.34 M
What is Athira Pharma TTM CFI year-on-year change?
Over the past year, ATHA TTM cash flow from investing activities has changed by $0.00 (0.00%)